Hangzhou Endonom Medtech Co., Ltd.

This trial tests a new device called WeFlow-EndoPatch, designed to seal remaining tears in the aorta after a previous dissection repair. The study includes adults with chronic aortic dissection who have distal tears needing closure. Participants are randomly assigned to receive e…

This study tests whether adding a special plug (WeFlow-EndoSeal™) to standard stent-graft repair improves outcomes for people with a tear in the aorta's inner layer (type B aortic dissection). About 256 adults with subacute or chronic dissection will be randomly assigned to get t…

This study tests a new device called the WeFlow-Tribranch stent graft system to repair aneurysms or ulcers in the aortic arch. About 90 people aged 18 to 80 with these conditions will receive the stent through a minimally invasive procedure. The main goal is to see if the device …